What Is Selank? A Research Compound Guide

What is Selank?

Selank is supplied strictly for laboratory and research use only. It is not intended for use in humans or animals, and nothing in this guide describes any such use. What follows is a research-level explanation of what the molecule is and why it appears across the scientific literature.

At a laboratory level, Selank is a short synthetic peptide belonging to the class of regulatory peptides studied in neuroscience research. It is a synthetic analogue of tuftsin, a naturally occurring peptide fragment associated with immune signalling. Selank has been characterised by researchers as a stabilised heptapeptide, meaning it is built from a defined sequence of seven amino acid residues arranged to improve stability under laboratory conditions compared with the parent tuftsin fragment.

Because it is a fully synthetic construct rather than an extract, Selank can be produced to a consistent, defined sequence, which is one reason it is favoured as a reference compound in mechanistic studies. When researchers refer to Selank, they are referring to this specific peptide identity, confirmed through analytical testing.

View Selank

Structure and molecular characteristics

Understanding what Selank is at a structural level helps explain why it is studied the way it is. The following points summarise the widely reported laboratory characteristics of the molecule.

• Class: a short synthetic peptide, described in the literature as a stabilised analogue of the endogenous peptide tuftsin.
• Composition: a heptapeptide, meaning it is assembled from seven amino acid residues in a defined sequence.
• Derivation: designed as a synthetic modification of the tuftsin fragment, engineered by researchers to increase stability for laboratory work.
• Category: catalogued within the cognitive research grouping, reflecting the neuroscience pathways where it has drawn research interest.
• Form: typically handled as a lyophilised (freeze-dried) peptide in a sealed research vial, reconstituted only within a controlled laboratory setting.

Why researchers study Selank

Research interest in Selank centres on its relationship to neurochemical signalling pathways and to immunomodulation, the study of how signalling molecules interact with immune-related processes. As a tuftsin analogue, it sits at an interesting intersection of neuroscience and immunology, which is part of why it has attracted attention as a study compound.

In preclinical and laboratory research, Selank has been investigated for its role in models used to explore neuropeptide and neurotransmitter signalling. This is framed entirely as mechanistic and model-based research interest. It describes what scientists examine when they include the peptide in a study design, not any outcome in a person or animal.

Its origin as a tuftsin analogue also makes it a candidate of interest in immunomodulation research, where investigators study how peptide structures interact with signalling systems at a cellular and biochemical level.

Preclinical pathways and research models

Within the cognitive and neuroscience research category, Selank is most often associated with studies exploring neurotransmitter and neuropeptide signalling. Researchers investigating signalling biology use defined reference peptides to probe how these systems behave under controlled experimental conditions, and Selank features in that context.

A second thread of laboratory interest relates to the broader family of regulatory peptides and how synthetic analogues can be stabilised while retaining a defined sequence. This makes Selank useful as a comparison or reference point when researchers characterise peptide behaviour, stability, and identity in the lab.

In every case, this research is preclinical and mechanistic. The scientific value lies in understanding pathways, models, and molecular behaviour, not in any application to living subjects. When Selank is described in the literature, it is described as a tool for investigating biology, and that is the only lens Pepology applies to it.

How to verify quality

For research to be meaningful, the identity and quality of the compound must be reliable. Every batch of Selank supplied by Pepology is third-party lab tested by Novagen Laboratories, and each batch carries a certificate of analysis that customers can verify independently.

A certificate of analysis typically documents the types of testing performed rather than any marketing claim. This generally includes identity confirmation, verifying that the material matches the expected peptide, and purity analysis by high performance liquid chromatography (HPLC). We report what the analysis covers and let the certificate itself carry the figures. We never invent numbers.

Use this checklist when verifying a batch:

• Locate the lot or batch number printed on the vial.
• Match that lot number to the certificate of analysis supplied for the batch.
• Confirm the certificate identifies Novagen Laboratories as the testing party.
• Check that the certificate documents identity confirmation and HPLC purity analysis.
• Independently verify the certificate rather than relying on a claim alone.

Verify a batch certificate

Sourcing Selank in Australia

Pepology is an Australian, Gold Coast owned and operated retailer of research peptides. For laboratories and researchers sourcing Selank in Australia, that means a locally operated supplier with third-party batch testing by Novagen Laboratories and a certificate of analysis available for every batch.

Selank is offered in the strengths listed on the store, and all material is supplied for laboratory and research use only. Sourcing with confidence comes down to traceability: a defined compound identity, transparent testing, and a certificate you can verify against the vial in front of you.

If you are equipping a study or restocking reference material, you can view the current Selank listing or explore the wider catalogue of research compounds below. All products remain strictly for laboratory and research use only.

View Selank Browse all research peptides